Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Steven M Condon
Introduction
Steven M Condon is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that addresses critical health issues. His work focuses on compounds that possess useful pharmaceutical properties, which can be vital in treating various diseases.
Latest Patents
Steven M Condon holds a patent for substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) compounds. This invention is directed to compounds of formula I, wherein the variables are as described in the patent documentation. The compounds within the scope of this invention are particularly useful for inhibiting the production or physiological effects of tumor necrosis factor (TNF). This is crucial for treating patients suffering from diseases associated with an excess of TNF. Additionally, these compounds inhibit cyclic AMP phosphodiesterase, making them useful in treating inflammatory and autoimmune diseases, particularly those related to type IV cyclic AMP phosphodiesterase. The patent also covers the pharmaceutical use of these compounds, their compositions, intermediates, and methods for their preparation.
Career Highlights
Steven M Condon is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of diseases linked to TNF and cyclic AMP phosphodiesterase.
Collaborations
Throughout his career, Steven has collaborated with notable colleagues, including Robert D Groneberg and Kent W Neuenschwander. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical field.
Conclusion
Steven M Condon's contributions to pharmaceutical innovations demonstrate the importance of research in developing effective treatments for complex health issues. His patent reflects a commitment to improving patient care through scientific advancements.